CAS 1609281-86-8

Fórmula: C21H23N5O4S

InChI: InChI=1S/C21H23N5O4S/c1-10-18(11(2)30-26-10)12-3-4-14(16(7-12)29-13-5-6-24-9-13)17-8-15(19(22)27)20(31-17)25-21(23)28/h3-4,7-8,13,24H,5-6,9H2,1-2H3,(H2,22,27)(H3,23,25,28)/t13-/m0/s1

Clave InChI: NMFIXEFNQPDISY-ZDUSSCGKSA-N

SMILES: CC1=C(C(=NO1)C)C2=CC(=C(C=C2)C3=CC(=C(S3)NC(=O)N)C(=O)N)O[C@H]4CCNC4

2-[(Aminocarbonyl)amino]-5-[4-(3,5-dimethyl-4-isoxazolyl)-2-[(3S)-3-pyrrolidinyloxy]phenyl]-3-thiophenecarboxamide

CAS: 1609281-86-8

Fórmula: C₂₁H₂₃N₅O₄S

Pureza: 99%

Forma y color: Solid

Peso molecular: 441.5034

Ref: IN-DA00ABN0

AZD3264

CAS: 1609281-86-8

AZD3264

Fórmula: C₂₁H₂₃N₅O₄S

Pureza: ≥98%

Peso molecular: 441.5

Ref: 54-BUP07115

AZD3264

CAS: 1609281-86-8

AZD3264 is a new type IKK2 inhibitor.

Fórmula: C₂₁H₂₃N₅O₄S

Pureza: 98.98% - 99.17%

Forma y color: Solid

Peso molecular: 441.5

Ref: TM-T6771

AZD3264

CAS: 1609281-86-8

AZD3264 is a matrix effect-based drug candidate that is currently being studied for its potential use in the treatment of chronic pulmonary diseases. The compound was synthesized by scalable synthesis and purified by chromatographic techniques. AZD3264 has been shown to have an effective dose against cancer cells in vitro and in vivo. It also has stem cell-like properties, which may make it more effective in regenerative therapies.

Fórmula: C₂₁H₂₃N₅O₄S

Pureza: Min. 95%

Peso molecular: 441.5 g/mol

Ref: 3D-JPC28186

AZD3264

CAS: 1609281-86-8

Pureza: ≥98%

Peso molecular: 441.147

Ref: 10-F870106